Sahraian, M. A., Abolfazli, R., Shaygannejad, V., Ashtari, F., Majdinasab, N., Navardi, S., . . . Albooyeh, S. (2024). Evaluating efficacy and safety of ocrelizumab biosimilar (Xacrel) compared to the originator (Ocrevus) in relapsing multiple sclerosis. Scientific Reports, 14(1), . https://doi.org/10.1038/s41598-024-75745-y
Chicago-referens (17:e uppl.)Sahraian, Mohammad Ali, et al. "Evaluating Efficacy and Safety of Ocrelizumab Biosimilar (Xacrel) Compared to the Originator (Ocrevus) in Relapsing Multiple Sclerosis." Scientific Reports 14, no. 1 (2024). https://doi.org/10.1038/s41598-024-75745-y.
MLA-referens (9:e uppl.)Sahraian, Mohammad Ali, et al. "Evaluating Efficacy and Safety of Ocrelizumab Biosimilar (Xacrel) Compared to the Originator (Ocrevus) in Relapsing Multiple Sclerosis." Scientific Reports, vol. 14, no. 1, 2024, https://doi.org/10.1038/s41598-024-75745-y.
